Background: Transvenous lead extraction (TLE) has become an essential component of lead management strategies, but it carries the risk of severe complications, including damage to the tricuspid valve. Currently, there are no established predictors that can help prevent these complications.

Case Summary: An 84-year-old male with a dual-chamber pacemaker was admitted to the hospital due to a pocket fistula resulting from a local infection. Approximately 1 year prior, he underwent the implantation of a new ventricular lead and pacemaker replacement due to lead damage and battery depletion. Another lead had been abandoned. The patient underwent a procedure to remove the entire pacing system, which was complicated by tricuspid leaflet avulsion, resulting in acute and severe tricuspid regurgitation. A biological valve was successfully implanted to replace the damaged valve. Twenty days later, a new pacing system was implanted, which included one atrial lead and another positioned in the posterolateral coronary vein of the left ventricle. Post-procedural transthoracic echocardiography (TTE) showed the biological valve in place at the tricuspid orifice, with no regurgitation and preserved ejection fraction. Following recovery, the patient was discharged in good condition.

Discussion: While pre-procedural TTE and intra-procedural transesophageal echocardiography are commonly used to identify lead-induced tricuspid insufficiency, they often do not clarify the underlying mechanisms or predict potential complications during TLE. To address this issue safely, further research into new imaging techniques is necessary, as some existing methods may not be adequate in certain situations.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11732274PMC
http://dx.doi.org/10.1093/ehjcr/ytae695DOI Listing

Publication Analysis

Top Keywords

transvenous lead
8
tricuspid valve
8
pacing system
8
biological valve
8
lead
7
tricuspid
6
valve
5
complications transvenous
4
lead extraction-focus
4
extraction-focus tricuspid
4

Similar Publications

A young man in his 30s presented to us with multiple episodes of syncope and exertional dyspnoea for the last 2 weeks. He was diagnosed with squamous cell carcinoma of the lower one-third of the oesophagus in 2021 for which he was treated with neoadjuvant chemoradiotherapy, followed by McKeown oesophagectomy. At 2-year follow-up, he had developed a soft tissue swelling in the scalp, which was diagnosed as a tumour recurrence and radiotherapy was initiated.

View Article and Find Full Text PDF

This case details the successful implantation of a leadless pacemaker following the extraction of transvenous leads in a 72-year-old female patient with a complex cardiovascular history. The patient had undergone a series of cardiac interventions, including a recent percutaneous tricuspid valve repair with a metal clip implant due to severe regurgitation. After presenting with an infection at the pacemaker site, methicillin-resistant Staphylococcus hominis was identified, necessitating the removal of the entire pacing system.

View Article and Find Full Text PDF

Objective: To compare the paced QRS duration on different sites in age-, gender-, and indication-matched patients implanted with Micra leadless pacemakers and conventional transvenous pacemakers (TV-PM).

Method: A total of 82 patients from Xinhua Hospital, Shanghai Jiaotong University, were enrolled, including two groups of 41 patients matched according to gender, age, and pacemaker indications, who underwent Micra and TV-PM implantations, respectively. The baseline data of the patients, the pacing site described using three- and nine-partition methods, and the paced QRS duration on 12-lead electrocardiogram were then analyzed.

View Article and Find Full Text PDF

Leadless Pacing: Current Status and Ongoing Developments.

Micromachines (Basel)

January 2025

Section of Electrophysiology, Division of Cardiology, Department of Internal Medicine, Rush University Medical Center, 1653 W. Congress, Chicago, IL 60612, USA.

Although significant strides have been made in cardiac pacing, the field is still evolving. While transvenous permanent pacing is highly effective in the management of bradyarrhythmias, it is not risk free and may result in significant morbidity and, rarely, mortality. Transvenous leads are often the weakest link in a pacing system.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!